FUSEN PHARM (01652.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec29

Fosun Pharmaceutical's Compound Potassium Phosphate Injection Approved by China's National Medical Products Administration

04:23

Nov14

Fosun Pharmaceutical's Alacepril Potassium Tablets Approved By China National Medical Products Administration

08:46

Oct30

Fosun Pharmaceutical Wins Bid in China's 11th National Drug Tender

09:13

Aug29

FUSEN PHARM released FY2025 Q1 earnings on August 29 (BJT), actual revenue HKD 59.59 M, actual EPS HKD -0.0167

15:00

FUSEN PHARM released FY2025 Q2 earnings on August 29 After-Market BJT, actual revenue HKD 60.9 M, actual EPS HKD -0.0164

11:00

FUSEN PHARM released FY2025 Semi-Annual earnings on August 29 After-Market (BJT), actual revenue HKD 120.49 M, actual EPS HKD -0.0338

11:00

Schedules & Filings

Schedules

Filings

Aug29

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 60.9 M, Net Income -12.66 M, EPS -0.0171

Mar31

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 68.99 M, Net Income -80.77 M, EPS -0.1092

Aug29

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 105.48 M, Net Income -19.85 M, EPS -0.0268

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More